{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:18:41Z","timestamp":1778656721969,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Anti-<jats:italic>Wolbachia<\/jats:italic> treatment with doxycycline is effective in sterilising and killing adult <jats:italic>Onchocerca volvulus<\/jats:italic> nematodes, proving superior to ivermectin and of great potential as an alternative approach for the treatment and control of onchocerciasis, particularly in areas of <jats:italic>Loa loa<\/jats:italic> co-endemicity. Nevertheless, the length of the required treatment poses potential logistical problems and risk of poor compliance, raising a barrier to the use of doxycycline in Mass Drug Administration (MDA) strategies. In 2007 and 2008 a feasibility trial of community-directed treatment with doxycycline was carried out in two health districts in Cameroon, co-endemic for <jats:italic>O. volvulus<\/jats:italic> and <jats:italic>L. loa<\/jats:italic>. With 17,519 eligible subjects, the therapeutic coverage was 73.8% with 97.5% compliance, encouraging the feasibility of using doxycycline community-directed delivery in restricted populations of this size. The current study evaluated the effectiveness of this community-directed delivery of doxycycline four years after delivery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Findings<\/jats:title>\n            <jats:p>Infection with <jats:italic>O. volvulus<\/jats:italic> was evaluated by skin biopsy and nodule palpation. Of the 507 subjects recruited, 375 had completed the treatment with doxycycline followed by one or two rounds of annual ivermectin MDA and 132 received one or two rounds of annual ivermectin MDA alone. Statistically significant lower microfilarial prevalence (17.0% [doxycycline plus ivermectin group], 27.0% [ivermectin only group], <jats:italic>p<\/jats:italic> = 0.014) and load (<jats:italic>p<\/jats:italic> = 0.012) were found in people that had received doxycycline followed by ivermectin compared to those who received ivermectin only.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This study demonstrates the long-term effectiveness of doxycycline treatment delivered with a community-directed strategy even when evaluated four years after delivery in an area of ongoing transmission. This finding shows that a multi-week course of treatment is not a barrier to community-delivery of MDA in restricted populations of this size and supports its implementation to compliment existing control strategies for onchocerciasis, where needed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1756-3305-5-53","type":"journal-article","created":{"date-parts":[[2012,3,20]],"date-time":"2012-03-20T13:15:38Z","timestamp":1332249338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Long term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasis"],"prefix":"10.1186","volume":"5","author":[{"given":"Francesca","family":"Tamarozzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Tendongfor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A","family":"Enyong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Esum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Faragher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Wanji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,20]]},"reference":[{"issue":"9","key":"552_CR1","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1371\/journal.pmed.0030371","volume":"3","author":"MG Basanez","year":"2006","unstructured":"Basanez MG, Pion SD, Churcher TS, Breitling LP, Little MP, Boussinesq M: River blindness: a success story under threat?. PLoS Med. 2006, 3 (9): e371-10.1371\/journal.pmed.0030371.","journal-title":"PLoS Med"},{"issue":"9747","key":"552_CR2","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S0140-6736(10)60586-7","volume":"376","author":"MJ Taylor","year":"2010","unstructured":"Taylor MJ, Hoerauf A, Bockarie M: Lymphatic filariasis and onchocerciasis. Lancet. 2010, 376 (9747): 1175-1185. 10.1016\/S0140-6736(10)60586-7.","journal-title":"Lancet"},{"issue":"5","key":"552_CR3","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S1473-3099(08)70099-9","volume":"8","author":"MG Basanez","year":"2008","unstructured":"Basanez MG, Pion SD, Boakes E, Filipe JA, Churcher TS, Boussinesq M: Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. Lancet Infect Dis. 2008, 8 (5): 310-322. 10.1016\/S1473-3099(08)70099-9.","journal-title":"Lancet Infect Dis"},{"issue":"9328","key":"552_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(02)09456-4","volume":"360","author":"J Gardon","year":"2002","unstructured":"Gardon J, Boussinesq M, Kamgno J, Gardon-Wendel N, Demanga N, Duke BO: Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial. Lancet. 2002, 360 (9328): 203-210. 10.1016\/S0140-6736(02)09456-4.","journal-title":"Lancet"},{"issue":"7","key":"552_CR5","first-page":"e497","volume":"3","author":"L Diawara","year":"2009","unstructured":"Diawara L, Traore MO, Badji A, Bissan Y, Doumbia K, Goita SF, Konate L, Mounkoro K, Sarr MD, Seck AF: Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS NTD. 2009, 3 (7): e497-","journal-title":"PLoS NTD"},{"issue":"11","key":"552_CR6","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/0169-4758(96)40006-0","volume":"12","author":"JP Chippaux","year":"1996","unstructured":"Chippaux JP, Boussinesq M, Gardon J, Gardon-Wendel N, Ernould JC: Severe adverse reaction risks during mass treatment with ivermectin in loiasis-endemic areas. Parasitol Today. 1996, 12 (11): 448-450. 10.1016\/0169-4758(96)40006-0.","journal-title":"Parasitol Today"},{"issue":"9070","key":"552_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0140-6736(96)11094-1","volume":"350","author":"J Gardon","year":"1997","unstructured":"Gardon J, Gardon-Wendel N, Demanga N, Kamgno J, Chippaux JP, Boussinesq M: Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet. 1997, 350 (9070): 18-22. 10.1016\/S0140-6736(96)11094-1.","journal-title":"Lancet"},{"issue":"3","key":"552_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00430-007-0062-1","volume":"197","author":"A Hoerauf","year":"2008","unstructured":"Hoerauf A, Specht S, Buttner M, Pfarr K, Mand S, Fimmers R, Marfo-Debrekyei Y, Konadu P, Debrah AY, Bandi C: Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study. Medical Microbiol Immunol. 2008, 197 (3): 295-311. 10.1007\/s00430-007-0062-1.","journal-title":"Medical Microbiol Immunol"},{"issue":"2","key":"552_CR9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00436-008-1217-8","volume":"104","author":"A Hoerauf","year":"2009","unstructured":"Hoerauf A, Specht S, Marfo-Debrekyei Y, Buttner M, Debrah AY, Mand S, Batsa L, Brattig N, Konadu P, Bandi C: Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus. Parasitol Res. 2009, 104 (2): 437-447. 10.1007\/s00436-008-1217-8.","journal-title":"Parasitol Res"},{"issue":"4","key":"552_CR10","first-page":"e660","volume":"4","author":"JD Turner","year":"2010","unstructured":"Turner JD, Tendongfor N, Esum M, Johnston KL, Langley RS, Ford L, Faragher B, Specht S, Mand S, Hoerauf A: Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial. PLoS NTD. 2010, 4 (4): e660-","journal-title":"PLoS NTD"},{"issue":"1","key":"552_CR11","first-page":"e72","volume":"1","author":"C Bourguinat","year":"2007","unstructured":"Bourguinat C, Pion SD, Kamgno J, Gardon J, Duke BO, Boussinesq M, Prichard RK: Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment. PLoS NTD. 2007, 1 (1): e72-","journal-title":"PLoS NTD"},{"issue":"39","key":"552_CR12","doi-asserted-by":"publisher","first-page":"16716","DOI":"10.1073\/pnas.0906176106","volume":"106","author":"TS Churcher","year":"2009","unstructured":"Churcher TS, Pion SD, Osei-Atweneboana MY, Prichard RK, Awadzi K, Boussinesq M, Collins RC, Whitworth JA, Basanez MG: Identifying sub-optimal responses to ivermectin in the treatment of River Blindness. Proc Natl Acad Sci USA. 2009, 106 (39): 16716-16721. 10.1073\/pnas.0906176106.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9578","key":"552_CR13","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/S0140-6736(07)60942-8","volume":"369","author":"MY Osei-Atweneboana","year":"2007","unstructured":"Osei-Atweneboana MY, Eng JK, Boakye DA, Gyapong JO, Prichard RK: Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet. 2007, 369 (9578): 2021-2029. 10.1016\/S0140-6736(07)60942-8.","journal-title":"Lancet"},{"issue":"3","key":"552_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1128\/CMR.00057-10","volume":"24","author":"F Tamarozzi","year":"2011","unstructured":"Tamarozzi F, Halliday A, Gentil K, Hoerauf A, Pearlman E, Taylor MJ: Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment. Clin Microbiol Rev. 2011, 24 (3): 459-468. 10.1128\/CMR.00057-10.","journal-title":"Clin Microbiol Rev"},{"key":"552_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2458-1-12","volume":"1","author":"WS Alley","year":"2001","unstructured":"Alley WS, van Oortmarssen GJ, Boatin BA, Nagelkerke NJ, Plaisier AP, Remme JH, Lazdins J, Borsboom GJ, Habbema JD: Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination. BMC Publ Health. 2001, 1: 12-10.1186\/1471-2458-1-12.","journal-title":"BMC Publ Health"},{"issue":"1","key":"552_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1756-3305-2-39","volume":"2","author":"S Wanji","year":"2009","unstructured":"Wanji S, Tendongfor N, Nji T, Esum M, Che JN, Nkwescheu A, Alassa F, Kamnang G, Enyong PA, Taylor MJ: Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon. Parasit Vectors. 2009, 2 (1): 39-10.1186\/1756-3305-2-39.","journal-title":"Parasit Vectors"},{"issue":"1","key":"552_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1475-2883-4-2","volume":"4","author":"S Wanji","year":"2005","unstructured":"Wanji S, Tendongfor N, Esum M, Yundze SS, Taylor MJ, Enyong P: Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon. Filaria J. 2005, 4 (1): 2-10.1186\/1475-2883-4-2.","journal-title":"Filaria J"},{"key":"552_CR18","unstructured":"A-WOL - Anti-Wolbachia Consortium. [http:\/\/www.a-wol.net\/]"},{"issue":"1","key":"552_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00436-009-1624-5","volume":"106","author":"S Specht","year":"2009","unstructured":"Specht S, Hoerauf A, Adjei O, Debrah A, Buttner DW: Newly acquired Onchocerca volvulus filariae after doxycycline treatment. Parasitol Res. 2009, 106 (1): 23-31. 10.1007\/s00436-009-1624-5.","journal-title":"Parasitol Res"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-3305-5-53.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T18:52:26Z","timestamp":1630522346000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/1756-3305-5-53"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,20]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["552"],"URL":"https:\/\/doi.org\/10.1186\/1756-3305-5-53","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,20]]},"assertion":[{"value":"28 January 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"53"}}